SCHEMBL6153567

SCHEMBL6153567

COC(=O)CC(CC(=O)OC)C(=O)OCc1ccccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
CASP3 P42574 3/20 0.49
SENP8 Q96LD8 3/20 0.49
SENP7 Q9BQF6 3/20 0.49
SENP6 Q9GZR1 3/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 3/20 0.49
MAPT P10636 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KMT2A Q03164 3/20 0.48
PKM P14618 2/20 0.48
NPC1 O15118 3/20 0.47
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP9 P14780 1/20 0.45
MMP12 P39900 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154257 0.85 L3MBTL1 (0.44) ALDH1A1HTTRAB9AMAPTL3MBTL1
SCHEMBL6153156 0.84 HPGD (0.49) ALDH1A1HTTRAB9AMAPTL3MBTL1
SCHEMBL6153644 0.84 ALDH1A1 (0.52) ALDH1A1HTTRAB9AMAPTL3MBTL1
SCHEMBL6154391 0.84 TSHR (0.49) ALDH1A1RAB9AMAPTKMT2APKM
SCHEMBL12617736 0.80 NPC1 (0.60) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL6153301 0.79 MAOB (0.48) ALDH1A1HTTRAB9AL3MBTL1KMT2A
SCHEMBL6153847 0.77 GAA (0.46) ALDH1A1HTTRAB9AMAPTL3MBTL1
SCHEMBL18802104 0.77 NPC1 (0.44) ALDH1A1HTTRAB9AMAPTKMT2A
SCHEMBL23135434 0.76 POLB (0.51) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL29242025 0.76 KMT2A (0.48) ALDH1A1CASP3SENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2005-06-02 US disclosed
EP-1500642-A1 3-SUBSTITUTED OXYGLUTARIC DIESTER COMPOUND, OPTICALLY ACTIVE 3-SUBSTITUTED OXYGLUTARIC MONOESTER COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these OGDH, GLUL, ADSL ALDH1A1 434/4885CASP3 2858/4885SENP8 3072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.